Plant roots respond to various internal and external signals and adjust themselves to changes of environmental conditions. In the root meristem, stem cells produce daughter cells that continue to divide several times. When these latter cells reach the transition zone, they stop dividing and enter the endocycle, a modified cell cycle in which DNA replication is repeated without mitosis or cytokinesis. The resultant DNA polyploidization, named endoreduplication, is usually associated with an increase of nuclear and cell volume and with cell differentiation [1] [2] [3] [4] . At the transition zone, cytokinin signaling activates two transcription factors, type-B ARABIDOPSIS RESPONSE REGULATOR 1 (ARR1) and ARR12, and induces SHY2/IAA3, a member of the Aux/IAA family of auxin signaling repressors. This inhibits auxin signaling and reduces the expression of auxin efflux carriers, resulting in cell division arrest [5] . Such counteracting actions of two hormones are assumed to determine meristem size. However, it remains unknown whether cytokinins additionally control meristem size through an auxinindependent pathway. Here we show that, in Arabidopsis, the cytokinin-activated ARR2 directly upregulates the expression of CCS52A1, which encodes an activator of an E3 ubiquitin ligase, anaphase-promoting complex/ cyclosome (APC/C) [6] , thereby promoting the onset of the endocycle and restricting meristem size. Our genetic data revealed that CCS52A1 function is independent of SHY2-mediated control of auxin signaling, indicating that downregulation of auxin signaling and APC/C-mediated degradation of cell-cycle regulators cooperatively promote endocycle onset, and thus fine tune root growth.
Plant roots respond to various internal and external signals and adjust themselves to changes of environmental conditions. In the root meristem, stem cells produce daughter cells that continue to divide several times. When these latter cells reach the transition zone, they stop dividing and enter the endocycle, a modified cell cycle in which DNA replication is repeated without mitosis or cytokinesis. The resultant DNA polyploidization, named endoreduplication, is usually associated with an increase of nuclear and cell volume and with cell differentiation [1] [2] [3] [4] . At the transition zone, cytokinin signaling activates two transcription factors, type-B ARABIDOPSIS RESPONSE REGULATOR 1 (ARR1) and ARR12, and induces SHY2/IAA3, a member of the Aux/IAA family of auxin signaling repressors. This inhibits auxin signaling and reduces the expression of auxin efflux carriers, resulting in cell division arrest [5] . Such counteracting actions of two hormones are assumed to determine meristem size. However, it remains unknown whether cytokinins additionally control meristem size through an auxinindependent pathway. Here we show that, in Arabidopsis, the cytokinin-activated ARR2 directly upregulates the expression of CCS52A1, which encodes an activator of an E3 ubiquitin ligase, anaphase-promoting complex/ cyclosome (APC/C) [6] , thereby promoting the onset of the endocycle and restricting meristem size. Our genetic data revealed that CCS52A1 function is independent of SHY2-mediated control of auxin signaling, indicating that downregulation of auxin signaling and APC/C-mediated degradation of cell-cycle regulators cooperatively promote endocycle onset, and thus fine tune root growth.
Results and Discussion
Hormonal signaling is likely to control the timing of endocycle onset, but little is known about the molecular mechanisms involved. Because cytokinin is known to restrict meristem size, we first examined whether it affects endocycle onset in the root tip. As reported previously, a 16 hr treatment with 1 mM transzeatin (tZ) decreased the number of dividing cells in the meristem and thus reduced the meristem size, which corresponds to the number of cortex cells between the quiescent center (QC) and the first elongated cell ( Figure 1A and Figure S1A available online) [7] . Conversely, cell elongation was delayed both in the cytokinin receptor mutant ahk3-1 ahk4-1, which is insensitive to exogenous cytokinin application in root elongation [8] , and in the cytokinin biosynthesis mutant ipt3-2 ipt5-1 ipt7-1 [9] (Figures 1A and S1A) . Accordingly, root growth was altered as shown in Figure S1B . We then visualized nuclei by DAPI staining and measured the DNA level (C-value) and cell length for each cell near the transition zone. We found a tight correlation between the two parameters, which was invariable, regardless of the integrity of cytokinin signaling ( Figure S1C ). This indicates that cell elongation in this area depends principally on DNA polyploidization and that cytokinin controls endocycle onset. To substantiate this result, we examined the correlation between distance from the QC and nuclear area, which is known to correlate well with DNA content [10] . In tZ-treated roots, an increase in nuclear area was noted in cells closer to the QC, whereas in the cytokinin-related mutants, the increase occurred in cells further from the QC (Figures 1B and 1C) . These results also indicate that cytokinin promotes the transition from the mitotic cell cycle to the endocycle and consequently increases the DNA level in cells closer to the QC and restricts the meristem size.
Endocycle onset requires a controlled decrease of mitotic cyclin-dependent kinase (CDK) activities [11] . A major cause of this reduction is the degradation of mitotic cyclins, mediated by an E3 ubiquitin ligase, anaphase-promoting complex/cyclosome (APC/C). APC/C activity is controlled by regulatory proteins, among which activators such as CDH1, Fizzy-related (FZR), and CCS52A are known to promote the onset and progression of the endocycle in human, Drosophila, and plants, respectively [6, 12, 13] . Arabidopsis has two genes for CCS52A, CCS52A1, and CCS52A2, and CCS52A1 is known to function in mitotic exit and endoreduplication; specifically, CCS52A1 downregulates the B1-type CDK activity by promoting degradation of its partner cyclin A2;3, leading to endocycle onset [6, 14, 15] . As reported previously, a b-glucuronidase (GUS) reporter line carrying the CCS52A1 promoter showed GUS expression in the transition and elongation/differentiation zones but not in the meristematic zone ( Figure 1D ) [15] . Maximal GUS expression was detected just above the meristematic zone, where endoreduplication starts to occur. In the epidermis, stronger GUS expression was observed in the hair cell layer than in the nonhair cell layer, for unknown reasons ( Figures 1D and 1E , wild-type). Nuclear-localized GFP expressed under the CCS52A1 promoter started to accumulate in a few cells preceding the first endoreduplicated cell ( Figure S1D and S1E), supporting the idea that CCS52A1 is involved in endocycle onset.
Because cytokinins appear to promote endoreduplication, as described above, we hypothesized that cytokinin signaling regulates CCS52A1 expression. To test this, we monitored CCS52A1 promoter activity under different cytokinin conditions. tZ treatment for 3 hr elevated ProCCS52A1:GUS expression in the transition and elongation/differentiation zones, but not in the meristematic zone ( Figure 1D ). This indicates that the spatial expression pattern of CCS52A1 is not dependent on cytokinin distribution in roots; rather, cytokinins modulate the transcript level. qRT-PCR also showed cytokinin-induced upregulation of CCS52A1 expression (Figure S1F ). In the cytokinin receptor mutants, CCS52A1 expression was reduced and restricted almost entirely to the transition zone ( Figures 1E and S1F ). Furthermore, overexpression of the cytokinin oxidase 2 (CKX2) gene, which lowers the endogenous cytokinin level by degrading active forms of cytokinins [16] , also resulted in a reduction of ProCCS52A1:GUS expression ( Figure 1E ). These results indicate that CCS52A1 expression is under the control of cytokinin signaling.
Plant cells respond to cytokinins through a two-component phosphorelay pathway, in which the phosphate group is transferred to the type-B ARABIDOPSIS RESPONSE REGULATOR (ARR) transcription factors. Phosphorylated type-B ARRs control transcription of cytokinin response genes [17] . To determine which part of the CCS52A1 promoter is necessary for cytokinin response, we made a deletion series from the 5 0 end and observed the promoter activity by generating GUSfusion genes. The results showed that deletion of the sequence between 2990 bp and 2890 bp from the start codon almost abolished the promoter activity ( Figures S2A and S2B ). This region contains one consensus ARR-binding sequence (5 0 -GATT-3 0 ) [18] at 2932 bp from the start codon. To test whether type-B ARRs can physically associate with the CCS52A1 promoter, we performed a yeast one-hybrid assay with two type-B ARRs, ARR1 and ARR2. Generally, the N-terminal region of type-B ARRs contains three separated amino acids (two aspartates and a lysine; the DDK domain), whose aspartates receive the phosphate group. Upon phosphorylation of the DDK domain, the N-terminal region loses its repressive function in transcriptional activation; thus, artificial removal of the N-terminal region generates a constitutive active ARR [18] . As shown in Figure 2A , ARR2 lacking the DDK domain (ARR2DDDK) associated with the 1.5 kb promoter region of CCS52A1, but no interaction was observed with full-length ARR2 or with ARR1, regardless of the DDK domain. We further examined in vivo targets of ARR2 by chromatin immunoprecipitation (ChIP) using Arabidopsis plants expressing hemagglutinin (HA)-tagged ARR2. Immunoprecipitation with anti-HA antibody followed by PCR with specific primer sets revealed that the highest enrichment of ARR2-bound chromatin was for the promoter region between 21000 bp and 2800 bp from the start codon ( Figures  2B and 2C ). This region corresponds to that required for GUS expression in the promoter deletion analysis (Figures S2A and  S2B ). These data demonstrate that CCS52A1 is a direct target of the active form of ARR2.
A transient activation assay using Arabidopsis protoplasts showed that the CCS52A1 promoter activity was induced by overexpression of ARR2DDDK and slightly increased by expression of full-length ARR2 ( Figure 2D ). The promoter activity in protoplasts transfected with full-length ARR2 was elevated by tZ application and reached the level of ARR2DDDK overexpression ( Figure S2C ), suggesting low cytokinin content in protoplasts. In contrast, no significant change was observed when the other type-B ARRs, ARR1, ARR10, and ARR12, with or without the DDK domain, were overexpressed ( Figure 2D ). In planta, CCS52A1 expression, which was monitored with the ProCCS52A1:GUS reporter gene and qRT-PCR, decreased in roots of the ARR2 knockout mutant arr2-4 (Figures 2E and S1F). However, its promoter activity was not altered in the ARR1 or ARR12 knockout mutants ( Figures  S2D and S2E ). These results demonstrate that ARR2 but not ARR1 or the other type-B ARRs induces CCS52A1 expression. ARR2-GUS fusion protein expressed under the ARR2 promoter started to accumulate in a few cells preceding the first elongated cell, as observed for the CCS52A1 promoter activity ( Figures 2F and 2G ) [19] , supporting the role of ARR2 in inducing CCS52A1 expression.
To determine whether ARR2-mediated induction of CCS52A1 plays a physiological role in the transition to the endocycle, we first measured root meristem size of ccs52a1 and arr2 mutants. As previously reported, the knockout mutant ccs52a1-1 had more cells in the meristematic zone than wild-type ( Figure 3 ) [15] . Root meristem size was reduced by tZ treatment in wild-type but less so in ccs52a1-1. arr2-4 and the other arr2 knockout mutants, arr2-3 and arr2-5, also had a larger meristem and showed lower sensitivity to tZ than wild-type (Figures 3 and S3A) . Furthermore, the root meristem phenotype of the ccs52a1-1 arr2-4 double mutant was nearly identical to that of ccs52a1-1 or arr2-4 single mutants ( Figure 3B ), suggesting that CCS52A1 and ARR2 function in the same pathway. By contrast, transgenic plants overexpressing ARR2 or CCS52A1 [6, 20] showed a significant reduction of meristematic cell number, and the sensitivity to tZ was higher in ARR2-overexpressing plants than in wild-type ( Figure 3B ). Similar trends were also observed when we measured root length and the distance between the QC and See also Figure S2 and Table S1. the first cell harboring an enlarged nucleus (as estimated by an increase of >1.5-fold in nuclear area; Figures S3B and S3C) . In arr2-4, ccs52a1-1 and arr2-4 ccs52a1-1, root growth in the absence of tZ was almost the same as that in wild-type (Figure S3C) , suggesting that ARR2 and CCS52A1 have another role in cell growth in the elongation/differentiation zone. These results indicate that cytokinin-triggered induction of endocycle onset and the resultant reduction in meristem size are associated with ARR2-mediated induction of CCS52A1.
A previous report showed that, in the transition zone, ARR1 and ARR12 induce the expression of SHY2 and repress auxin signaling and PIN-FORMED1 (PIN1) expression, resulting in cell division arrest [5] . Although ARR1 and ARR12 are not associated with CCS52A1 expression, as described above, the possibility remained that CCS52A1 affects auxin signaling and inhibits cell division. To address this point, we applied indole-3-acetic acid (IAA) and the auxin antagonist a-(phenyl ethyl-2-one) (PEO)-IAA [21] to the ccs52a1 mutant. The root meristem size of ccs52a1-1 was increased by IAA treatment and reduced by PEO-IAA treatment in a similar fashion to that of wild-type roots ( Figures S3D and S3E) . Moreover, exogenous IAA treatment did not affect the expression level of CCS52A1 in wild-type roots ( Figure S3F ). These results suggest that CCS52A1 functions independently of the auxinmediated regulation of meristem size.
We next examined the relationship between the ARR2-CCS52A1 and ARR1/AAR12-SHY2 pathways. As mentioned above, the number of meristematic cells was elevated in ccs52a1-1, and we found that the arr1-3 arr12-1 double mutant showed a similar degree of meristem enlargement (Figures 4A Five-day-old seedlings were treated with or without 1 mM tZ for 16 hr, and cell number was counted. Data are presented as mean 6 SD (n > 30). Significant differences from the nontreated control were determined by Student's t test: **p < 0.01; ***p < 0.001. See also Figure S3 . and 4B) [5] . However, the arr1-2 arr12-1 ccs52a1-1 triple mutant displayed a much larger meristem ( Figures 4A and  4B) . Similarly, shy2-31 ccs52a1-1 double mutants exhibited a larger meristem than either shy2-31 or ccs52a1-1 (Figures S4A and S4B) . tZ treatment reduced the meristem size in wild-type and had a milder effect in ccs52a1-1 or arr1-3 arr12-1, but the arr1-2 arr12-1 ccs52a1-1 triple mutant was completely insensitive to tZ ( Figures 4A and 4B) . We again observed similar trends when root length and the distance between the QC and the first cell harboring an enlarged nucleus were measured ( Figures S3B,  S4C, and S4D ). These data demonstrate that both ARR2-CCS52A1 and ARR1/ARR12-SHY2 pathways are crucial for the control of endocycle onset and root meristem size through cytokinin signaling.
We noticed that, in the presence of tZ, ARR2 overexpression reduced meristem size more severely than CCS52A1 overexpression ( Figures 3B and S3B) . Moreover, ARR2 overexpression in ccs52a1-1 reduced the meristem size relative to that in ccs52a1-1, and this effect was enhanced by tZ treatment (Figures 3B and S3B) . These results indicate that ARR2 regulates not only CCS52A1 but also other factors involved in the control of endocycle onset and meristem size. One possibility is that ARR2, like ARR1 and ARR12, suppresses auxin signaling by controlling SHY2 expression. Our measurement of the SHY2 transcript level showed that SHY2 expression decreased in arr2-4, as observed in arr1-3, arr12-1, and arr1-3 arr12-1 ( Figure S4E ). This indicates that ARR2 regulates not only CCS52A1 but also SHY2 expression and controls auxin signaling. However, as mentioned above, the extent of meristem enlargement observed in arr2-4 was almost the same as that in ccs52a1-1, and arr2-4 was not fully resistant to tZ ( Figure 3B ). Therefore, whereas ARR2-mediated control of CCS52A1 contributes substantially to endocycle onset, a group of type-B ARRs (ARR1, ARR2, and ARR12) cooperates in the upregulation of SHY2 expression and suppression of auxin signaling.
In summary, this study has shown that cytokinin controls endocycle onset and meristem size through an auxin-independent pathway; namely, cytokinin-activated ARR2 directly induces the expression of CCS52A1, which activates the E3 ubiquitin ligase APC/C and promotes the degradation of mitotic regulators, causing cell division to cease ( Figure 4C ). This pathway is distinct from the ARR1/ARR12-SHY2 pathway, in which cytokinin counteracts auxin and inhibits cell division ( Figure 4C ; [5] ). It is likely that the ARR2-CCS52A1 pathway acts in the precise control of endocycle onset by promoting the degradation of cell-cycle regulators in the transition zone, thereby fine tuning meristem size. In this study, we also found that ARR2 regulates not only CCS52A1 but also SHY2 expression ( Figure 4C ). Choi et al. [20] reported that ARR2 functions in the defense response with another transcription factor, TGA3, via a direct interaction. Therefore, in the transition zone of roots, ARR2 may have a specific interaction partner to bind to the CCS52A1 promoter but not to the SHY2 promoter, which is recognized also by ARR1 and ARR12 [5] . A recent report showed that the ubiquitin-proteasome pathway brings about immediate degradation of the ARR2 protein [19] , suggesting that ARR2-mediated control of the cell cycle is strictly regulated at multiple levels. Further studies on ARR2 target genes will reveal how cytokinins control the phase change from the mitotic cell cycle to the endocycle and how they contribute to cell growth and differentiation in roots.
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